Showing results (51-60 of 182) with videos related to
Sort By:
Pageof 19
Pathology, Research and Practice|November 13, 2023
Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppressionIbrahim H Eissa, Reda G Yousef, Muhammad Sami, et al.Bioorganic Chemistry|May 8, 2021
Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agentsSouad A El-Metwally, Mohsen M Abou-El-Regal, Ibrahim H Eissa, et al.Life (Basel, Switzerland)|January 21, 2023
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD StudyIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.Plos One|March 9, 2023
Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approachIbrahim H Eissa, Reda G Yousef, Eslam B Elkaeed, et al.Chemistryopen|October 6, 2023
A Theobromine Derivative with Anticancer Properties Targeting VEGFR-2: Semisynthesis, in silico and in vitro StudiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.European Journal of Medicinal Chemistry|July 12, 2023
2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profilingMoataz A Shaldam, Denisa Hendrychová, Radwan El-Haggar, et al.Drug Development Research|May 3, 2026
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer ActivityHazem Elkady, Walid E Elgammal, Ibrahim H Eissa, et al.Pathology, Research and Practice|October 19, 2023
Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studiesIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|December 12, 2023
Comparative metabolic study of the chloroform fraction of three Cystoseira species based on UPLC/ESI/MS analysis and biological activitiesShaza H Aly, Ahmed M Elissawy, Mahmoud A El Hassab, et al.Future Medicinal Chemistry|June 16, 2026
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activityWalid E Elgammal, Hazem Elkady, Aisha A Alsfouk, et al.Pageof 19